🧬 Company Directory
Biotech portfolio companies advancing drug discovery, diagnostics, genomics, and therapeutics backed by specialized life sciences investors.
13 companies
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.
A San Diego biotech company focused on biological genesis and creation processes, backed by $42M in Series A funding.
An early-stage Cambridge biotech company serving as a nexus in the biopharmaceutical industry with $2.8M pre-seed funding.
A Basel-based regenerative medicine company with $150M in Series C funding, developing advanced regenerative therapies and technologies.
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
Biotechnology company developing protein engineering and synthetic biology platforms for drug discovery and development.
A Cambridge-based biotech company developing neurological therapeutics and treatments.